Application progress of pulmonary function test in airway obstruction caused by Mycoplasma pneumoniae pneumonia in children
LI Zi-long1 LIU Xian1 TANG Hong-ping1,2▲ SHA Yong-hong1
1. Jishou University School of Medicine, Hu′nan Province, Jishou 416000, China;
2. Department of Pediatrics, the First People′s Hospital of Changde City, Hu′nan Province, Changde 415000, China
Abstract:With changes in the environment and the development of pathogenic detection methods, Mycoplasma pneumoniae (MP) has gradually become one of the main pathogens causing respiratory infections in children. In addition to symptoms such as cough and fever, MP infection can also cause airway damage, which is mainly manifested as obstructive ventilation dysfunction. Pulmonary function testing (PFT) is a clinical testing technique based on respiratory physiology and an important testing method for describing respiratory function. Whether in the acute phase or recovery phase of mycoplasma pneumoniae pneumonia (MPP), PFT can accurately determine the ventilatory dysfunction caused by MP infection and assess the severity of lung ventilatory damage. MP infection in children with asthma can induce asthma attacks and significantly reduce their lung ventilation function. In the treatment of children with asthma and MP infection, the recovery of lung ventilation function can be evaluated by comparing the changes of lung function related indicators in the acute phase and the recovery phase, and then the therapeutic effect can be evaluated. This article will review the latest research on the application of PFT to children′s MPP in recent years and put forward prospects.
李子龙;刘娴;唐红平,;沙永红. 肺功能检测在儿童肺炎支原体肺炎致气道阻塞中的应用进展[J]. 中国当代医药, 2021, 28(12): 47-050.
LI Zi-long1 LIU Xian1 TANG Hong-ping1,2▲ SHA Yong-hong1. Application progress of pulmonary function test in airway obstruction caused by Mycoplasma pneumoniae pneumonia in children. 中国当代医药, 2021, 28(12): 47-050.
Kjaer BB,Jensen JS,Nielsen KG,et al.Lung function and bronchial responsiveness afterMycoplasma pneumoniaeinfection in early childhood[J].Pediatr Pulmonol,2008,43(6):567-575.
Li G,Fan L,Wang Y,et al.High co-expression of TNF-alpha and CARDS toxin is a good predictor for refractoryMycoplasma pneumoniaepneumonia[J].Mol Med,2019,25(1):38.
Xu W,Yang H,Liu H,et al.Bronchoalveolar lavage T cell cytokine profiles and their association with lung function in children withMycoplasma pneumoniae-associated bronchiolitis obliterans[J].Pediatr Pulmonol,2020,55(8):20332 040.
[18]
Young RP,Hopkins R,Eaton TE.Forced expiratory volume in one second:not just a lung function test but a marker of premature death from all causes[J].Eur Respir J,2007,30(4):616-662.
[19]
Rhim JW,Kang HM,Yang EA,et al,Epidemiological relationship betweenMycoplasma pneumoniaepneumonia and recurrent wheezing episode in children:an observational study at a single hospital in Korea[J].BMJ Open,2019,9(4):e26461.
Kassisse E,Garcia H,Prada L,et al.Prevalence ofMycoplasma pneumoniaeinfection in pediatric patients with acute asthma exacerbation[J].Arch Argent Pediatr,2018,116(3):179-185.
[30]
Shi Y,Aledia AS,Galant SP,et al.Peripheral airway impairment measured by oscillometry predicts loss of asthma control in children[J].J Allergy Clin Immunol,2013,131(3):718-723.